Qiagen vs. Illumina, the next Big Fight in Next-gen Sequencing
Next-gen sequencing is a revolution. San Diego-based Illumina owns most of the market but German giant…
Next-gen sequencing is a revolution. San Diego-based Illumina owns most of the market but German giant…
2 weeks ago, I was at NOAH15 in Berlin, one of the biggest European events…
[Update: On June 19, Puretech successfully raised $171M - approximately €150M - during its IPO,…
Qiagen has launched its Qiagen Clinical Insight bioinformatics content and software platform. The software aims…
Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the…
GATC Biotech has signed a commercial agreement with Molecular Health to market and support Molecular…
Cambridge-based Optibrium has launched of version 6.1 of its StarDrop platform to guide researchers in…
The latest version of the Vitic Intermediates database, chemical database and information management system, has been…
The French company, Sartorius Stedim Biotech (SSB), announced that the 2015 version of the Ambr…
Sophia Genetics has become the first European company to obtain a CE-IVD mark allowing the use of their…